Enovis (ENOV) Total Debt Growth (1y) (2011 - 2026)
Powered by 
Analysis
Enovis (ENOV) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 12.29% |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | -6.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | -6.49% |
| Apr 3, 2026 | -3.31% |
| Dec 31, 2025 | -1.31% |
| Oct 3, 2025 | 1.03% |
| Jul 4, 2025 | 3.98% |
| Apr 4, 2025 | 3.60% |
| Dec 31, 2024 | 189.50% |
| Sep 27, 2024 | 245.70% |
| Jun 28, 2024 | 239.87% |
| Mar 29, 2024 | 376.72% |
| Dec 31, 2023 | -2.59% |
| Sep 29, 2023 | -56.04% |
| Jun 30, 2023 | -55.50% |
| Mar 31, 2023 | -88.57% |
| Dec 31, 2022 | -77.15% |
| Sep 30, 2022 | -45.23% |
| Jul 1, 2022 | -44.42% |
| Apr 1, 2022 | -15.13% |
| Dec 31, 2021 | -7.27% |
| Oct 1, 2021 | -26.95% |